I. Introduction
Technology in the medical field has evolved over the years and
gradually gave birth to alternate reproductive options, by
introducing the Assisted Reproductive Technology (Regulation) Act,
of 2021 (ART Act). The ART Act marks a significant
legislative intervention in India's healthcare landscape. The
Act encompasses framework to govern reproductive procedures,
ensuring transparency, accountability, liability, and ethical
practices in ART clinics/banks. By safeguarding the interests of
donors, commissioning parents, and children born through ART, it
addresses enduring concerns of exploitation, commercialisation, and
regulatory vacuum in the reproductive health sector. This paper
attempts to critically analyse the ART Act, by examining its
interplay with the Surrogacy (Regulation) Act, of 2021
(Surrogacy Act), and highlights emerging judicial
trends shaping the interpretation of these laws, particularly
concerning and reproductive rights.